Skip to content

FARMACON: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

FARMACON

BE 0439.169.181
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€16,845
2024 · -€48,514+€65,359
Equity
€229,617
2024 · €212,772+€16,845
Cash
€72,456
2024 · €109,049-€36,593
Balance sheet total
€929,902
2024 · €1.0m-€97,736

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€88,426

    down €88,426 (-13.6%), from €652,120 to €563,694

    of which Land and buildings: -€56,818

  • Cash -€36,593

    down €36,593 (-33.6%), from €109,049 to €72,456

    mainly Debts after one year (-€57,886) and Other debts (-€32,794)

  • Deferred charges and accrued income +€20,175

    up €20,175 (+22.0%), from €91,538 to €111,713

Equity and liabilities
  • Debts after one year -€57,886

    down €57,886 (-11.8%), from €491,026 to €433,140

  • Other debts -€32,794

    down €32,794 (-51.6%), from €63,538 to €30,744

  • Accrued charges and deferred income -€21,188

    down €21,188 (-70.2%), from €30,170 to €8,983

  • Profit (loss) carried forward +€16,845

    up €16,845 (+1.5%), from -€1.1m to -€1.1m

  • Current portion of long-term debt -€15,469

    down €15,469 (-21.1%), from €73,356 to €57,886

Income statement
  • Gross operating margin +€55,344

    up €55,344 (+23.3%), from €237,955 to €293,299

  • Depreciation -€5,000

    down €5,000 (-5.3%), from €93,603 to €88,603

  • Financial charges -€3,175

    down €3,175 (-66.0%), from €4,815 to €1,639

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€48,514
Gross operating margin +€55,344
Staff costs +€2,054
Depreciation +€5,000
Other operating charges -€24
Financial income -€82
Financial charges +€3,175
Taxes -€109
Result 2025 €16,845
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€36,763
Investment €0
Financing -€73,356
Cash 2024 €109,049
Net result for the year +€16,845
Depreciation +€88,603
Stocks and contracts -€4,004
Receivables within one year -€3,281
Deferred charges and accrued income -€20,175
Trade debts +€3,399
Tax, wage and social debts +€9,358
Other debts -€32,794
Accrued charges and deferred income -€21,188
Debts after one year -€57,886
Current portion of long-term debt -€15,469
Cash 2025 €72,456
brings cash intakes cash out
Every line side by side 48 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,027,638 €929,902 -€97,736 -9.5%
Fixed assets 21/28 €652,596 €563,993 -€88,603 -13.6%
Intangible fixed assets 21 €177 - -€177
Tangible fixed assets 22/27 €652,120 €563,694 -€88,426 -13.6%
Land and buildings 22 €489,310 €432,492 -€56,818 -11.6%
Plant, machinery and equipment 23 €135,477 €110,865 -€24,611 -18.2%
Furniture and vehicles 24 €27,333 €20,336 -€6,997 -25.6%
Financial fixed assets 28 €300 €300 = 0.0%
Current assets 29/58 €375,042 €365,909 -€9,133 -2.4%
Stocks and contracts in progress 3 €148,626 €152,630 +€4,004 +2.7%
Stocks 30/36 €148,626 €152,630 +€4,004 +2.7%
Amounts receivable within one year 40/41 €25,829 €29,110 +€3,281 +12.7%
Trade receivables 40 €5,998 €29,048 +€23,050 +384%
Other amounts receivable 41 €19,831 €62 -€19,769 -99.7%
Cash at bank and in hand 54/58 €109,049 €72,456 -€36,593 -33.6%
Deferred charges and accrued income 490/1 €91,538 €111,713 +€20,175 +22.0%
Total equity and liabilities 10/49 €1,027,638 €929,902 -€97,736 -9.5%
Equity 10/15 €212,772 €229,617 +€16,845 +7.9%
Contributions 10/11 €1,170,000 €1,170,000 = 0.0%
Reserves 13 €133,496 €133,496 = 0.0%
Tax-exempt reserves 132 €126 €126 = 0.0%
Distributable reserves 133 €133,369 €133,369 = 0.0%
Profit (loss) carried forward 14 -€1,090,724 -€1,073,879 +€16,845 +1.5%
Amounts payable 17/49 €814,866 €700,285 -€114,581 -14.1%
Amounts payable after more than one year 17 €491,026 €433,140 -€57,886 -11.8%
Financial debts 170/4 €491,026 €433,140 -€57,886 -11.8%
Amounts payable within one year 42/48 €293,670 €258,163 -€35,507 -12.1%
Current portion of amounts payable after more than one year 42 €73,356 €57,886 -€15,469 -21.1%
Trade debts 44 €138,396 €141,794 +€3,399 +2.5%
Suppliers 440/4 €138,396 €141,794 +€3,399 +2.5%
Taxes, remuneration and social security 45 €18,381 €27,738 +€9,358 +50.9%
Taxes 450/3 €109 €3,782 +€3,673 +3,373%
Remuneration and social security 454/9 €18,272 €23,957 +€5,685 +31.1%
Other amounts payable 47/48 €63,538 €30,744 -€32,794 -51.6%
Accrued charges and deferred income 492/3 €30,170 €8,983 -€21,188 -70.2%
Remuneration, social security and pensions 62 €187,376 €185,322 -€2,054 -1.1%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €93,603 €88,603 -€5,000 -5.3%
Other operating charges 640/8 €2,521 €2,545 +€24 +0.9%
Gross operating margin 9900 €237,955 €293,299 +€55,344 +23.3%
Operating profit (loss) 9901 -€45,545 €16,829 +€62,374
Financial income 75/76B €2,176 €2,094 -€82 -3.8%
Recurring financial income 75 €2,176 €2,094 -€82 -3.8%
Financial charges 65/66B €4,815 €1,639 -€3,175 -66.0%
Recurring financial charges 65 €4,815 €1,639 -€3,175 -66.0%
Profit (loss) for the period before taxes 9903 -€48,184 €17,283 +€65,467
Income taxes 67/77 €329 €438 +€109 +33.1%
Profit (loss) for the period 9904 -€48,514 €16,845 +€65,359
Profit (loss) for the period to be appropriated 9905 -€48,514 €16,845 +€65,359

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.